| 1 |
33400134 | UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy. | 2021 Aug |
1 |
| 2 |
34000957 | Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children. | 2021 Jul |
3 |
| 3 |
34133540 | Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy. | 2021 |
2 |
| 4 |
34656038 | CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study. | 2021 Nov |
3 |
| 5 |
32107351 | Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy. | 2020 Oct |
2 |
| 6 |
33553069 | Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy. | 2020 |
1 |
| 7 |
30686291 | A meta-analysis of the influence of UGT1A6 genetic polymorphisms on valproic acid pharmacokinetics
. | 2019 Mar |
4 |
| 8 |
28841884 | Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. | 2017 Aug 25 |
1 |
| 9 |
27232006 | UGT1A6- and UGT2B7-related valproic acid pharmacogenomics according to age groups and total drug concentration levels. | 2016 Jun |
1 |
| 10 |
27855134 | Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China. | 2016 Dec |
1 |
| 11 |
25751467 | Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy. | 2015 Jan-Feb |
5 |
| 12 |
23749495 | The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach. | 2013 Oct |
7 |
| 13 |
22476391 | Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. | 2012 Oct |
2 |
| 14 |
22838952 | Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid. | 2012 Jul |
2 |
| 15 |
23099353 | Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. | 2012 |
1 |
| 16 |
17925173 | [Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate]. | 2007 Aug 7 |
5 |
| 17 |
15470160 | Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes. | 2005 Jan |
1 |
| 18 |
15761113 | UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). | 2005 Jun |
1 |
| 19 |
12732356 | The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. | 2003 May 1 |
1 |